Is Navitas Stock a Buy or Sell After a Director Dumps Shares Worth $1.6 Million?

On Dec. 12, 2025 Board member Dr. Ranbir Singh indirectly sold 179,354 shares of Navitas Semiconductor (NVTS) via SiCPower, LLC at $8.68 per share for roughly $1.6 million, trimming his indirect stake by 31.55% from 568,450 to 389,096 shares. The sale price was marginally above the Dec. 12 close ($8.59) and substantially smaller than his recent median sell size, reflecting prior large disposals earlier in 2025. Navitas, a GaN power-IC designer, has a $1.68 billion market cap, TTM revenue of $56.6 million, reported Q3 sales of $10.1 million versus $21.7 million a year earlier, is unprofitable and trades at a high price-to-sales multiple (~27), making the insider selling after a strong 1-year price run-up (≈146%) a negative signal for investors.

Analysis

Market structure: Insider selling (31.6% of remaining indirect stake) in NVTS amplifies a liquidity event for a small-cap ($1.68B) GaN pure-play trading at P/S ~27 with TTM revenue $56.6M and a YoY Q3 revenue collapse (21.7M -> 10.1M). Winners are incumbent power-semiconductor suppliers (ON, STM) and OEMs that can source reliable GaN at scale; losers are NVTS equity holders, smaller ODM customers facing supply/qualification risk, and retail momentum flows. Options implied vols should spike near-term; impact on credit/FX is negligible outside the semiconductor supply chain.

Risk assessment: Tail risks include a customer concentration loss or a design-win reversal that could reduce FY revenue by >30% (high-impact within 3–6 months), and regulatory export or China-market access restrictions that would impair sales (12–24 months). Immediate risk (days) is further insider/officer selling driving price discovery; short-term (weeks–months) risk is an earnings miss or negative guidance; long-term risk (quarters/years) is slower-than-expected GaN adoption or margin compression versus silicon incumbents. Hidden dependency: NVTS valuation assumes rapid data-center AI content growth; if content-per-board stalls, cash burn and funding risk accelerate.

Trade implications: Direct short NVTS conviction vs naked long is highest-probability: target 2–4% net portfolio short via options to cap risk. Pair trade: short NVTS / long ON (ON) or STM (STM) to capture relative execution; size 1–2% net. Options: buy 3–6 month ATM puts or put spreads on NVTS (target >30% downside) and sell OTM calls on any remaining long exposure to fund premium. Rotate 1–3% from small-cap GaN names into large-cap power semis and diversification into analog chip makers over 6–18 months.

Contrarian angles: The market may be conflating GaN secular demand with company-specific execution — NVTS could be oversold if management quickly secures a $50–100M backlog or a marquee design win within 90 days, which would compress the short. Historical parallels: small-cap semiconductor dislocations (e.g., 2018 GaN pullbacks) reversed when OEM design-win cadence accelerated; watch design-win announcements and cash runway as binary catalysts. Unintended consequence: aggressive shorting could create opportunities for activist or strategic buyer interest if shares trade below replacement/technology value, so keep position size manageable and time-limited.

Key Decisions for Investors

• Establish a 2–4% portfolio short exposure to NVTS using 3–6 month ATM put options or put spreads (limit initial capital risk to 0.5% of NAV), and set a stop-loss if NVTS rises >20% from entry or if insider selling halts and a material buyback/design-win is announced within 30 days.
• Initiate a 1–2% pair trade: short NVTS and long ON Semiconductor (ON) or STMicro (STM) equal dollar weight for 6–18 months to capture relative execution and scale advantages; rebalance if NVTS revenue improves by >15% QoQ or ON/STM report negative earnings surprises.
• If you currently own NVTS, trim position by 50% within 5 trading days and fully exit if next quarter revenue misses consensus by >10% or if insiders sell an additional >5% of float within 30 days; use remaining shares to sell 1–3 month covered calls to monetize premium.
• Reallocate 1–3% of equity exposure from small-cap GaN pure-plays into large-cap power-semiconductor names (ON, STM) and analog suppliers over a 3–12 month horizon, targeting total return outperformance if GaN adoption proves slower than priced into NVTS.